UnitedHealth Group (NYSE:UNH) Trading Down 1%

Shares of UnitedHealth Group Incorporated (NYSE:UNHGet Free Report) were down 1% during trading on Monday . The company traded as low as $493.73 and last traded at $496.27. Approximately 1,260,079 shares were traded during trading, a decline of 72% from the average daily volume of 4,508,290 shares. The stock had previously closed at $501.13.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently commented on UNH shares. Oppenheimer reissued an “outperform” rating and set a $610.00 price target on shares of UnitedHealth Group in a research note on Wednesday, January 17th. Wells Fargo & Company decreased their price objective on shares of UnitedHealth Group from $600.00 to $525.00 and set an “overweight” rating on the stock in a research report on Monday, April 8th. HSBC upgraded shares of UnitedHealth Group from a “reduce” rating to a “hold” rating and set a $460.00 target price for the company in a research report on Thursday, April 4th. Royal Bank of Canada cut their price objective on UnitedHealth Group from $596.00 to $555.00 and set an “outperform” rating for the company in a research report on Wednesday, April 17th. Finally, Deutsche Bank Aktiengesellschaft boosted their price target on UnitedHealth Group from $545.00 to $562.00 and gave the stock a “buy” rating in a report on Friday, April 19th. Four analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $570.05.

Get Our Latest Analysis on UNH

UnitedHealth Group Stock Down 1.0 %

The firm has a 50-day moving average of $487.49 and a two-hundred day moving average of $514.76. The company has a current ratio of 0.85, a quick ratio of 0.79 and a debt-to-equity ratio of 0.69. The firm has a market capitalization of $448.40 billion, a PE ratio of 29.73, a price-to-earnings-growth ratio of 1.42 and a beta of 0.54.

UnitedHealth Group (NYSE:UNHGet Free Report) last announced its quarterly earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share for the quarter, beating analysts’ consensus estimates of $6.63 by $0.28. UnitedHealth Group had a net margin of 4.05% and a return on equity of 26.50%. The firm had revenue of $99.80 billion for the quarter, compared to analysts’ expectations of $99.23 billion. During the same period in the previous year, the company posted $6.26 earnings per share. UnitedHealth Group’s revenue was up 8.6% compared to the same quarter last year. On average, equities research analysts forecast that UnitedHealth Group Incorporated will post 27.61 EPS for the current year.

UnitedHealth Group Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, March 19th. Stockholders of record on Monday, March 11th were paid a $1.88 dividend. The ex-dividend date was Friday, March 8th. This represents a $7.52 dividend on an annualized basis and a dividend yield of 1.55%. UnitedHealth Group’s dividend payout ratio (DPR) is currently 45.97%.

Insider Buying and Selling

In other news, EVP Erin Mcsweeney sold 1,236 shares of the company’s stock in a transaction on Friday, March 8th. The shares were sold at an average price of $483.48, for a total value of $597,581.28. Following the completion of the transaction, the executive vice president now directly owns 9,364 shares in the company, valued at $4,527,306.72. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. In other news, EVP Erin Mcsweeney sold 1,236 shares of the company’s stock in a transaction dated Friday, March 8th. The shares were sold at an average price of $483.48, for a total value of $597,581.28. Following the sale, the executive vice president now owns 9,364 shares in the company, valued at approximately $4,527,306.72. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, CAO Thomas E. Roos sold 858 shares of the business’s stock in a transaction dated Friday, February 23rd. The shares were sold at an average price of $525.79, for a total value of $451,127.82. Following the completion of the sale, the chief accounting officer now directly owns 32,289 shares of the company’s stock, valued at $16,977,233.31. The disclosure for this sale can be found here. 0.35% of the stock is currently owned by corporate insiders.

Institutional Trading of UnitedHealth Group

Institutional investors and hedge funds have recently made changes to their positions in the stock. Robbins Farley bought a new stake in UnitedHealth Group in the 3rd quarter valued at about $25,000. Richelieu Gestion SA acquired a new stake in UnitedHealth Group in the 4th quarter valued at approximately $26,000. CGC Financial Services LLC grew its stake in shares of UnitedHealth Group by 1,000.0% in the fourth quarter. CGC Financial Services LLC now owns 55 shares of the healthcare conglomerate’s stock worth $29,000 after purchasing an additional 50 shares in the last quarter. True Wealth Design LLC bought a new stake in shares of UnitedHealth Group during the fourth quarter valued at about $31,000. Finally, NewSquare Capital LLC raised its stake in shares of UnitedHealth Group by 340.0% in the 3rd quarter. NewSquare Capital LLC now owns 66 shares of the healthcare conglomerate’s stock worth $33,000 after buying an additional 51 shares in the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.

UnitedHealth Group Company Profile

(Get Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Featured Articles

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.